4591 — Ribomic Cashflow Statement
0.000.00%
- ¥4bn
- ¥772m
Annual cashflow statement for Ribomic, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -854 | -1,186 | -1,684 | -1,652 | -1,023 |
Depreciation | |||||
Non-Cash Items | 15.1 | 21.6 | 34.9 | -3.2 | 46.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -81.3 | -11.4 | 134 | -54.1 | 33.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -902 | -1,149 | -1,499 | -1,709 | -933 |
Capital Expenditures | -46.8 | -1.59 | -10.4 | -23.9 | -22.7 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 600 | -1,698 | 700 | 300 | 200 |
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 553 | -1,700 | 690 | 276 | 177 |
Financing Cash Flow Items | -196 | — | — | 1.32 | 0.528 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 537 | 4,989 | 355 | 1,334 | 27.6 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 188 | 2,138 | -436 | -76.6 | -725 |